Vesper Medical is an innovative brand that specializes in developing therapeutic devices to treat deep venous disease. Their flagship product, the Vesper DUO Venous Stent System®, is a next-generation venous stent portfolio designed to address the unique challenges of the deep venous system. It offers a solution for patients with Chronic Venous Insufficiency (CVI) by providing superior anatomical support for the iliac or common femoral veins.

Currently, Vesper Medical is conducting the VIVID Clinical Trial, which is recruiting adult patients with CVI who are eligible for a venous stent. This trial aims to generate new insights into the effectiveness of venous stenting and explore the potential benefits of using the DUO-HYBRID and DUO-EXTEND stents, which may reduce the need to mix different stent types. With a commitment to advancing vascular care, Vesper Medical is shaping the future of deep venous disease treatment.

Their dedication to innovation and patient well-being has attracted attention, as demonstrated by their recent acquisition by Philips. To stay updated with Vesper Medical's breakthroughs, follow them on LinkedIn and Twitter